Literature DB >> 16191419

Specific siRNA downregulated TLR9 and altered cytokine expression pattern in macrophage after CpG DNA stimulation.

Bin Qiao1, Baohua Li, Xiuli Yang, Hongyong Zhang, Yiwei Chu, Ying Wang, Sidong Xiong.   

Abstract

Bacterial CpG DNA or synthetic oligonucleotides (ODNs) that contain unmethylated CpG motifs (CpG ODN) can directly activate antigen-presenting cells (APCs) to secrete various cytokines through the intracellular receptor TLR9. Cytokine profiles elicited by the actions of stimulatory CpG DNA on TLR9 expressed APCs are crucial to the subsequent immune responses. To date, cytokine profiles in APCs upon CpG ODN stimulation in vitro are not fully investigated. In the present study, vector-based siRNA was used to downregulate TLR9 expression. Cytokine profiles were observed in murine macrophage cell line RAW264.7 transfected with TLR9-siRNA plasmid upon CpG ODN stimulation. We found that not all the cytokine expressions by the macrophage were decreased while TLR9 was downregulated. IL-12, TNF-alpha, IFN-gamma and IL-1beta expressions were significantly decreased, but IL-6, IFN-beta and IL-10 expressions were not affected. Interestingly, the level of IFN-alpha was even increased. This alteration of cytokines produced by TLR9-downregulated APCs upon CpG ODN stimulation might indicate that the role of CpG DNA is more complicated in the pathogenesis and prevention of diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16191419

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  4 in total

1.  Macrophages are essential for antitumour effects against weakly immunogenic murine tumours induced by class B CpG-oligodeoxynucleotides.

Authors:  Ilia N Buhtoiarov; Paul M Sondel; Jens C Eickhoff; Alexander L Rakhmilevich
Journal:  Immunology       Date:  2006-12-08       Impact factor: 7.397

2.  DNase Sda1 allows invasive M1T1 Group A Streptococcus to prevent TLR9-dependent recognition.

Authors:  Satoshi Uchiyama; Federica Andreoni; Reto A Schuepbach; Victor Nizet; Annelies S Zinkernagel
Journal:  PLoS Pathog       Date:  2012-06-14       Impact factor: 6.823

3.  Epigallocatechin-3-gallate suppresses proinflammatory cytokines and chemokines induced by Toll-like receptor 9 agonists in prostate cancer cells.

Authors:  Sushovita Mukherjee; Mohammad Adnan Siddiqui; Shubham Dayal; Yasmine Zakaria Ayoub; Krishnamurthy Malathi
Journal:  J Inflamm Res       Date:  2014-06-17

Review 4.  Toll-like receptor 9 in breast cancer.

Authors:  Jouko Sandholm; Katri S Selander
Journal:  Front Immunol       Date:  2014-07-22       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.